سعر تاناتريل 5مجم 14 اقراص 2022
Tanatril 5mg 14 tab- المادة الفعالة: Imidapril
- Hikma Pharma
- عن طريق الفم
الفئة: خافض لضغط الدم
معلومات الدواء
التفاصيل الكاملةعن الدواءAbout the medicine
Imidapril 5 mg tablets, pack of 14, marketed in Egypt by Hikma Pharma (ACE inhibitor antihypertensive).
Imidapril 5 mg tablets, pack of 14, marketed in Egypt by Hikma Pharma (ACE inhibitor antihypertensive).
دواعي الاستعمالUses
- Treatment of essential hypertension in adults.الفئة: AdultsNorthumbria Pharma Ltd (UK MAH)
- Treatment of essential hypertension in adults.Population: AdultsNorthumbria Pharma Ltd (UK MAH)
الآثار الجانبيةSide effects
- Common: cough. Uncommon: headache, dizziness, hypotension, rash, pruritus. Rare: insomnia, dysgeusia, tinnitus, palpitations, nausea, vomiting, diarrhoea, abdominal pain, renal impairment, proteinuria, oedema, fatigue.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- Common: cough. Uncommon: headache, dizziness, hypotension, rash, pruritus. Rare: insomnia, dysgeusia, tinnitus, palpitations, nausea, vomiting, diarrhoea, abdominal pain, renal impairment, proteinuria, oedema, fatigue.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
موانع الاستعمالContraindications
- Hypersensitivity to imidapril, any other ACE inhibitor or excipients; history of ACE-inhibitor angioedema; hereditary/idiopathic angioedema; second and third trimesters of pregnancy; renal failure (CrCl < 10 ml/min); aliskiren in patients with diabetes or GFR < 60 ml/min/1.73 m2; concomitant sacubitril/valsartan.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- Hypersensitivity to imidapril, any other ACE inhibitor or excipients; history of ACE-inhibitor angioedema; hereditary/idiopathic angioedema; second and third trimesters of pregnancy; renal failure (CrCl < 10 ml/min); aliskiren in patients with diabetes or GFR < 60 ml/min/1.73 m2; concomitant sacubitril/valsartan.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
تحذيرات واحتياطاتWarnings & precautions
- May cause profound hypotension, especially after the first dose in volume-depleted patients or severe heart failure; start with 2.5 mg under close supervision in high-risk patients.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- Neutropenia/agranulocytosis, thrombocytopenia and anaemia reported rarely with ACE inhibitors; extreme caution in collagen vascular disease, immunosuppression, allopurinol or procainamide treatment, especially with renal impairment.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- Hyperkalaemia may occur, especially with renal insufficiency, diabetes, potassium-sparing diuretics, potassium supplements or salt substitutes.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- May cause profound hypotension, especially after the first dose in volume-depleted patients or severe heart failure; start with 2.5 mg under close supervision in high-risk patients.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
- Neutropenia/agranulocytosis, thrombocytopenia and anaemia reported rarely with ACE inhibitors; extreme caution in collagen vascular disease, immunosuppression, allopurinol or procainamide treatment, especially with renal impairment.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
- Hyperkalaemia may occur, especially with renal insufficiency, diabetes, potassium-sparing diuretics, potassium supplements or salt substitutes.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
التداخلات الدوائيةDrug interactions
- Potassium-sparing diuretics / potassium supplements / potassium-containing salt substitutesMay cause significant, potentially lethal increases in serum potassium, especially with renal impairment; avoid unless hypokalaemia, and monitor potassium.Northumbria Pharma Ltd (UK MAH)
- Non-potassium-sparing diureticsRisk of sudden hypotension and/or acute renal impairment when starting the ACE inhibitor in salt/volume-depleted patients.Northumbria Pharma Ltd (UK MAH)
- Potassium-sparing diuretics / potassium supplements / potassium-containing salt substitutesMay cause significant, potentially lethal increases in serum potassium, especially with renal impairment; avoid unless hypokalaemia, and monitor potassium.Northumbria Pharma Ltd (UK MAH)
- Non-potassium-sparing diureticsRisk of sudden hypotension and/or acute renal impairment when starting the ACE inhibitor in salt/volume-depleted patients.Northumbria Pharma Ltd (UK MAH)
الحمل والرضاعةPregnancy & breastfeeding
- When pregnancy is diagnosed, stop the ACE inhibitor immediately and start alternative therapy if appropriate.نشرة دولية لنفس التركيبة · Northumbria Pharma Ltd (UK MAH)
- When pregnancy is diagnosed, stop the ACE inhibitor immediately and start alternative therapy if appropriate.International label, same formulation · Northumbria Pharma Ltd (UK MAH)
كيف يعمل الدواءHow it works
- Prodrug converted to imidaprilat, which inhibits angiotensin-converting enzyme and reduces angiotensin II formation.
- Imidapril: Prodrug converted to imidaprilat, which inhibits angiotensin-converting enzyme and reduces angiotensin II formation.
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Hikma Pharma
- الكابرس تريو 10/320/25مجم 14 قرصأقراص مغلفة118ج.م
- الكابرس تريو 5/160/25مجم 14 قرصأقراص مغلفة110ج.م
- اميتربتين 75مجم اس ار كبسولاتكبسولات ممتدة المفعول4.5ج.م
- Asenapine-Hikma 10 mg 30 sublingual tabs.أقراص تحت اللسان298.5ج.م
- Asenapine-Hikma 2.5 mg 30 sublingual tabs.أقراص تحت اللسان182ج.م
- اسينابين 5مجم 30 قرص تحت اللسانأقراص تحت اللسان298.5ج.م
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- Northumbria Pharma Ltd (UK MAH)
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا